WGS logo

GENEDX HOLDINGS CORP

WGSNASDAQ
🏆 #1954 by market capUS Equity
$64.65▲ $2.07 (+3.31%)
Pre-market · at close
🔔
Track WGS
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 3.3%
7d▼ 3.8%
14d▼ 8.1%
30d▼ 14.7%
ytd▼ 50.3%
1y▼ 50.9%
🏦Market Cap
$1.93B
Small Cap
📈Revenue Growth (YoY)
40.0%
High Growth
📊Gross Margin
68.2%
High
💵FCF Margin
-16.7%
Thin
⚖️P/S Ratio
4.1x
Fair
Otter Score
80
Strong

Trading Snapshot

Day Range
$64.39 – $67.31
52-Week Range
$32.21 – $170.87
Volume (shares)
26,641
Avg Volume (shares)
—
Shares Outstanding
29.8M
Next Earnings
—

Fundamentals Snapshot

Annual Revenue
$428M
Last Q Revenue
$114M
P/E Ratio
-17.2
P/S Ratio
4.1x
EPS (TTM)
$-3.58
Dividend Yield
0.00%
Dilution (1yr)
−0.4%
WGS logo

GENEDX HOLDINGS CORP

WGS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$428M▲ +40.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
69.7%▲ +9.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$12M▼ −49.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$14M▼ −142.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
26.9M▼ −0.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$47M▼ −$16M YoY
StockOtter · stockotter.space

About GENEDX HOLDINGS CORP

GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Strong
80/100
Analyst data unavailable.

Latest News & Updates

News unavailable.